RecruitingPHASE1, PHASE2NCT06826859

Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)

Studying Preeclampsia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Thomas Jefferson University
Intervention
Daily aspirin (ASA)(drug)
Enrollment
400 target
Eligibility
16-55 years · FEMALE
Timeline
20252029

Study locations (1)

Collaborators

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06826859 on ClinicalTrials.gov

Other trials for Preeclampsia

Additional recruiting or active studies for the same condition.

See all trials for Preeclampsia

← Back to all trials